BioCentury
ARTICLE | Clinical News

Amoxicillin clavulanate regulatory update

January 11, 2010 8:00 AM UTC

Ranbaxy's Ohm Laboratories Inc. unit received a warning letter from FDA citing certain current good manufacturing practices (cGMP) violations at the company's liquid manufacturing facility in Gloversv...